Login or sign up
For business

Pharmabiome ag

3.9· 11 reviews
Average ratingAverage
3.9/ 5

Based on 11 reviews

527%
436%
336%
20%
10%
Ask AI

Questions about Pharmabiome ag

Based on 11 reviews, listing data and website checks · updated 5 days ago

What is Pharmabiome ag?

PharmaBiome is a pre-clinical stage spinoff from ETH Zurich that specializes in isolating, characterizing, and developing novel intestinal microbes. Their technology platform optimizes the lean and efficient development and production of defined, function-based microbiome therapies to treat intestinal diseases using tailored bacterial mixtures.

Where is Pharmabiome ag located and what industry does it serve?

PharmaBiome is located at Wagistrasse 27 in Schlieren, Switzerland, and operates within the biotechnology industry. The company focuses on creating function-based consortia at scale to address particular diseases by engineering bacterial consortia based on their metabolic interactions.

How long has Pharmabiome ag existed and what major milestones have they achieved?

The company was established starting in the mid-2000s, with scientific insights growing substantially following clinical proof-of-concept demonstrations with fecal transplants. They have adapted their technology to rapidly create and co-culture bacterial mixes for pre-clinical models showing promise in inflammatory and cancerous diseases.

What is the core technology and development pipeline of Pharmabiome ag?

PharmaBiome's proprietary development pipeline allows a fast translation from the identification of mode of action to a product ready for clinics. Their approach involves a bottom-up method where individual strains are selected, assembled, and co-cultured using groundbreaking technology to reverse dysbiosis.

Who are Pharmabiome ag's key partners and what recent collaborations have they entered?

The company collaborates with partners such as Ferring, Roquette, and others, as evidenced by their new microbiome R&D collaboration and exclusive licensing agreement with Ferring announced in December 2023. They also work on developing tailored fibers to modify the microbiome and its activity.

What scientific publications and research outputs has Pharmabiome ag produced?

PharmaBiome's research behind co-cultivation technology was published in the journal Gut Microbes on February 16, 2023, and they also published a paper on stratifying gut microbiomes by succinotype linked to inflammatory bowel disease in September 2024.

What is the stated vision and mission of Pharmabiome ag?

The company's vision is to become the global leader in microbiome translation, advancing effective drug products through rigorous science. They aim to turn microbiome information into actionable levers for targeted treatment of microbiome-linked conditions.

How can visitors contact Pharmabiome ag for specific purposes?

PharmaBiome offers direct contact channels for investor relations, collaborations, contributions, team joining, and press inquiries, each with a dedicated e-mail address. They also provide a general contact e-mail and phone number for Wagistrasse 27, Schlieren.

What is the current rating and review history for Pharmabiome ag on Trustburn?

The Trustburn rating for Pharmabiome ag is 3.9 out of 5 from 11 reviews, with the most recent feedback coming from November 2023. The reviews are overwhelmingly positive, with scores ranging from 3 to 5 stars.

What specific aspects of Pharmabiome ag do customers praise most?

Reviewers consistently praise Pharmabiome ag for top-notch products, exceptional customer service, and professional, knowledgeable teams that go above and beyond to ensure satisfaction. Many customers express high intent to recommend the company to others.

What is the scientific perspective on microbiome function that drives Pharmabiome ag's approach?

PharmaBiome's unique technologies allow them to access the entire range of intestinal bacteria for the design and production of function-based consortia. They believe the smallest relevant biological unit is the function delivered by intestinal bacteria, not just the bacterial strain.

How does Pharmabiome ag's therapeutic approach differ from standard FMT?

The company's therapies go beyond fecal microbiota transplantation (FMT) by targeting the introduction of specific functionality through a tailored consortium of bacteria. This consortium is mixed and co-cultured to reverse dysbiosis in a specific disease context.

Who comprises the leadership and team structure of Pharmabiome ag?

PharmaBiome's board, advisors, and operational team combine key expertise in microbiology, biotechnology, and molecular disease mechanisms involving the microbiome. The company is a spinoff from ETH Zurich, leveraging academic research for commercial application.

What recent news and events have been associated with Pharmabiome ag?

The company's news section highlights activities such as TEDxZurich talks on rebuilding gut health and collaborations with Roquette on tailored fibers. They also share updates on their R&D collaborations and scientific publications.

What is the official website of Pharmabiome ag?

The official website of Pharmabiome ag is pharmabiome.com.

AI-generated from reviews on this page. Verify anything important with the company directly.

News

No news yet. This is where the business shares its own updates and press.

Photos

Widgets

Boost your business trust by displaying a widget on your website — a simple way to convert your visitors into customers.

Get the widget for your site →

About Pharmabiome ag

PharmaBiome is specialized in the isolation, characterization, and technology of novel intestinal microbes. Their technology platform optimizes the lean and efficient development and production of defined, function-based microbiome therapies to treat intestinal diseases.

PharmaBiome’s proprietary development pipeline allows a fast translation from the identification of mode of action to a product ready for clinics, using tailored, ecologically sound bacterial mixtures.

Categories
Biotechnology